Close X

Attorney Spotlight

How does Eli Richardson's past work with the federal government inform his client interactions? Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

In June 2016, AmSurg Corp. and Envision Healthcare Holdings, Inc. (Envision) announced they have signed a definitive merger agreement pursuant to which the companies will combine in an all-stock transaction. Upon completion of the merger, which is expected to be tax-free to the shareholders of both organizations, the combined company will be named Envision Healthcare Corporation and co-headquartered in Nashville, Tennessee and Greenwood Village, Colorado. The company's common stock is expected to trade on the New York Stock Exchange under the ticker symbol: EVHC. Bass, Berry & Sims served as lead counsel on the transaction, led by Jim Jenkins. Read more.

AmSurg logo


Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Inside the FCA blogInside the FCA blog features ongoing updates related to the False Claims Act (FCA), including insight on the latest legal decisions, regulatory developments and FCA settlements. The blog provides timely updates for corporate boards, directors, compliance managers, general counsel and other parties interested in the organizational impact and legal developments stemming from issues potentially giving rise to FCA liability.

Read More >

Price W. Wilson

Member

Nashville
(615) 742-7820 TEL
(615) 248-2390 FAX

Price W. Wilson

Member

Nashville
(615) 742-7820 TEL
(615) 248-2390 FAX
Nashville
(615) 742-7820 TEL
(615) 248-2390 FAX

Working across a variety of industries, including the healthcare, financial, and food and beverage industries, Price Wilson represents both targets and acquirers in connection with merger and acquisition activity and issuers in connection with debt and equity offerings. Price's practice has encompassed deals worth nearly $8 billion to financing transactions valued at more than $800 million in aggregate.

Price's practice involves:

  • Corporate governance
  • Sarbanes-Oxley Act compliance
  • Public company disclosure
  • Section 16 issues and current reporting
  • Mergers and acquisitions
  • Joint ventures
  • Public debt and equity offerings
  • Private placements of securities.

Price's experience also includes representing U.S. and foreign clients engaged in cross-border transactions.

Memberships

American Health Lawyers Association (AHLA)

News

View More

Representative Experience

View More

Accolades

International Law Review Association — Editor

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.